State Street Corp Bio Affinity Technologies, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, State Street Corp holds 17,600 shares of BIAF stock, worth $33,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,600
Previous 17,600
-0.0%
Holding current value
$33,792
Previous $25,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
240KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA70.3KShares$135,0250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA42.1KShares$80,7890.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny37.5KShares$72,0000.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$53,5390.0% of portfolio
-
Northern Trust Corp Chicago, IL13.7KShares$26,2310.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $5.24M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...